Lunar continues to post improvingfinancial numbers. The Madison, WI, company last month reportedsharply higher results for the third quarter of 1994 (end-March). Total revenues for the quarter increased 21%, to $8 millionfrom $6.6 million in the same
Lunar continues to post improvingfinancial numbers. The Madison, WI, company last month reportedsharply higher results for the third quarter of 1994 (end-March).
Total revenues for the quarter increased 21%, to $8 millionfrom $6.6 million in the same period the year before. Net incomefor the quarter jumped 73%, to $2 million compared to $1.2 millionin the second quarter of 1993. The jump in Lunar's financial resultsis due to strong sales of its Achilles line, according to thecompany.
While Achilles is surging, Lunar reported that it has experienceddelays in finalizing the system integration of hardware and softwarefor its Expert high-end bone densitometry system. While severalbeta sites have been successfully installed, the company doesnot expect extensive shipments of Expert during the current fiscalyear.
Lunar is also the exclusive North American distributor forEsaote Biomedica's Artoscan niche MRI system.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.